Given CELSR2 is a transmembrane receptor, and our study advised that CELSR2 abundance is inversely associated with plasma LDL-C level and can protect against CAD, activating CELSR2 could hold promise for treating dyslipidaemia and CAD. Here, CELSR2 is linked to inherited lipid metabolism disorder.